Christoph B Wiedenroth, Kristin Steinhaus, Andreas Rolf, Andreas Breithecker, Miriam S D Adameit, Steffen D Kriechbaum, Moritz Haas, Fritz Roller, Christian W Hamm, H-Ardeschir Ghofrani, Eckhard Mayer, Stefan Guth, Christoph Liebetrau
BACKGROUND: Balloon pulmonary angioplasty (BPA) is a promising interventional treatment for inoperable chronic thromboembolic pulmonary hypertension (CTEPH). Evidence in favor of BPA is growing, but long-term data remain scarce. The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) is validated for the assessment of patients with pulmonary hypertension within three domains: symptoms, activity, and quality of life (QoL). The aim of the present study was to evaluate the long-term effects of BPA on these domains in patients with inoperable CTEPH...
August 29, 2023: Thoracic and Cardiovascular Surgeon